Anacor Pharma (ANAC) Tops Q4 EPS by 37c

Anacor Pharma (NASDAQ: ANAC) reported Q4 EPS of ($0.24), $0.37 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $9.6 million, versus $8.4 million reported last year.

For earnings history and earnings-related data on Anacor Pharma (ANAC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)